MarketPeel
Insider Trading Intelligence
PH

P. Kent Hawryluk

MBX
PRESIDENT & CEO · MBX BIOSCIENCES, INC. · CIK 0001673991
FILING MIX · LIFETIME58%/42%
BUYS
11
SELLS
8
TOTAL VALUE
$2.41M
COMPANIES
1
ACTIVE SINCE
Sep 2024
HOLDINGS NOW
727,667
AVG SELL PX
$29.54
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 11 pending
Forward-return performance of every backtestable P/S trade by P. Kent Hawryluk, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+7.11%+0.44%+6.67%+9.25%
14d4+75.00%+10.24%-0.28%+15.73%+6.04%
30d4+75.00%+24.74%+0.16%+24.57%+6.14%
60d4(1 pending)+66.67%+33.70%-0.98%+34.68%+20.61%
90d4(1 pending)+100.00%+66.27%+2.16%+64.11%+16.51%
180d4(2 pending)+100.00%+76.02%+5.49%+70.53%+70.53%
1y4(3 pending)+100.00%+251.05%+14.37%+236.68%+236.68%
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
MBX · 727,667 shares · as of May 6, 2026
0182,069364,137546,206728,27420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 11 buys / 8 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
607$29.54$17.9K727,667May 6, 2026May 8, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
President & CEO
18,500$28.41$525.7K486,777Mar 13, 2026Mar 16, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
President & CEO
28,768$16.00$460.3K728,274Feb 26, 2026Feb 27, 2026View →
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
28,76891,668Feb 26, 2026Feb 27, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
35,250699,506Feb 2, 2026Feb 3, 2026View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
164,500164,500Feb 2, 2026Feb 3, 2026View →
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
182,859129,708Oct 24, 2025Oct 28, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
President & CEO
182,859$3.25$594.3K664,256Oct 24, 2025Oct 28, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
President & CEO
20,000$13.64$272.8K468,277Oct 20, 2025Oct 21, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
President & CEO
50,000$10.69$534.5K448,277Feb 4, 2025Feb 5, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
243,000243,000Feb 3, 2025Feb 5, 2025View →
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
1,396,7620Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
76,9690Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
2,015,6810Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
970,8730Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
President & CEO
345,7050Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
President & CEO
115,914398,277Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
President & CEO
283,846481,397Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
120,436120,436Sep 12, 2024Sep 13, 2024View →
Other insiders · MBX
Loading peer insiders…
About this filer
CIK 0001673991
ROLE
President & CEO
PRIMARY
MBX
COMPANIES
1
ACTIVE SINCE
Sep 2024
MARKETPEEL · /INSIDER/0001673991DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback